We have set up our new Discord server! Share your feedback and find like-minded people! Join our Discord

Ticker
OPTN

Price
9.60
Stock movement down
-0.11 (-1.13%)
Company name
OptiNose
Exchange
(NASDAQ
,
Currency
USD
)
Sector
Healthcare >
Drug Manufacturers - Specialty & Generic
Market cap
97.22M
Ent value
186.84M
Price/Sales
1.28
Price/Book
-
Div yield
-
Div growth
-
Growth years
-
FCF payout
-
Trailing P/E
-
Forward P/E
-
PEG
-
EPS growth
-34.78%
1 year return
-50.39%
3 year return
-29.29%
5 year return
-30.33%
10 year return
-
Last updated: 2025-09-15

DIVIDENDS

OPTN does not pay dividends or no data was received

VALUATION

Valuation Ratios

Valuation Ratios data
Trailing P/E-
Price to OCF-
Price to FCF-
Price to EBITDA-
EV to EBITDA-

Valuation (Sales/Book Value)

Valuation (Sales/Book Value) data
Price to Sales1.28
Price to Book-
EV to Sales2.47

FINANCIALS

Per share

Per share data
Current share count10.13M
EPS (TTM)-2.68
FCF per share (TTM)-3.42

Income statement

Income statement data
Revenue (TTM)75.67M
Gross profit (TTM)68.06M
Operating income (TTM)-19.19M
Net income (TTM)-31.15M
EPS (TTM)-2.68
EPS (1y forward)-

Margins

Margins data
Gross margin (TTM)89.94%
Operating margin (TTM)-25.36%
Profit margin (TTM)-41.16%

Balance Sheet

Please create a free account or log in to access this chart
Balance Sheet data
Cash82.50M
Net receivables29.77M
Total current assets128.22M
Goodwill0.00
Intangible assets0.00
Property, plant and equipment0.00
Total assets131.02M
Accounts payable3.78M
Short/Current long term debt126.99M
Total current liabilities162.43M
Total liabilities172.12M
Shareholder's equity-41.10M
Net tangible assets0.00

Cash flow

Please create a free account or log in to access this chart
Cash flow data
Operating cash flow (TTM)-39.64M
Capital expenditures (TTM)145.00K
Free cash flow (TTM)-39.79M
Dividends paid (TTM)0.00

Financial returns

Please create a free account or log in to access this chart
Financial returns data
Return on Equity-
Return on Assets-23.77%
Return on Invested Capital-36.26%
Cash Return on Invested Capital-46.32%

STOCK INFORMATION

Stock chart

Stock price data
Open9.67
Daily high9.72
Daily low9.48
Daily Volume0K
All-time high446.40
1y analyst estimate21.00
Beta-0.89
EPS (TTM)-2.68
Dividend per share-
Ex-div date-
Next earnings date-

Downside potential

Downside potential data
OPTNS&P500
Current price drop from All-time high-97.85%-3.28%
Highest price drop-98.88%-56.47%
Date of highest drop14 Jan 20259 Mar 2009
Avg drop from high-78.65%-10.99%
Avg time to new high101 days12 days
Max time to new high1727 days1805 days
COMPANY DETAILS
OPTN (OptiNose) company logo
Marketcap
97.22M
Marketcap category
Small-cap
Description
OptiNose, Inc., a specialty pharmaceutical company, focuses on the development and commercialization of products for patients treated by ear, nose, throat, and allergy specialists. It offers XHANCE, a therapeutic product utilizing its proprietary exhalation delivery system (EDS) that delivers a topically acting corticosteroid for the treatment of chronic rhinosinusitis with nasal polyps, as well as is in Phase III clinical trial for treatment of chronic sinusitis; and Onzetra Xsail, a powder EDS device. The company was founded in 2000 and is headquartered in Yardley, Pennsylvania. As of May 21, 2025, OptiNose, Inc. operates as a subsidiary of Paratek Pharmaceuticals, Inc.
Employees
127
Website
https://www.optinose.com
Investor relations
-
SEC filings
OPTN SEC filings
CEO
Peter Kaighn Miller
Country
USA
City
Yardley
Stock type
Common stock
CCC status
-
Dividend Frequency
-
EVENTS AND PRESENTATIONS
EventsPresentations
UNDERSTAND THE BUSINESS
COMPANY NEWS
Seeking AlphaPress releases
No items found
iO Charts is a Seeking Alpha partner
Disclaimer
Skyfall Technology OÜ assumes no responsibility or liability for any errors or omissions in the content of this site. The information contained in this site is provided on an “as is” basis with no guarantees of completeness, accuracy, usefulness or timeliness. Please also note, that any action you take upon the information provided on this website is strictly at your own risk. This website is intended to be used and must be used for informational purposes only and you should take independent financial advice from a professional and independently research and verify everything you see on the site.
Menu
HomePortfolio ManagementCompany ScreenerGreen InvestmentExchangesFeatured ArticlesContact Us
Language
ENHUNOSVDAFIESDENLFRITPTPLCSSKROELTRRUAF
© 2024 Skyfall Technology OÜ All Rights Reserved